Zymergen researches, develops, and manufactures microbes for Fortune 500 companies. The company's objective is to engineer tiny microbes with the aid of advanced computing to help increase the yields from its customers’ fermentation processes. Zymergen co-founder and CEO Joshua Hoffman indicates that one of the biggest opportunities for his company is to produce entirely new products that are untethered to traditional petroleum-based manufacturing, which currently underpins nearly all manufacturing, from gas to golf bags, from dishwasher parts to dresses.
More specifically, Zymergen develops molecules for agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care, among other applications. Zymergen’s platform integrates automation, machine learning, and genomics to navigate the genomic search space, and it uses its technology platform to purportedly optimize strains that improve economics; improve the existing production strains within existing manufacturing processes; and improve the correlation between the lab and commercial manufacturing. Moreover, according to Zymergen, it offers new product development, such as engineering any molecules from any microbes that improve the power of biology to develop novel products.
Jed Dean, Joshua J. Hoffman, and Zachary Serber founded Zymergen in 2013, with its headquarters in Emeryville in California with an additional office in Seattle in Washington.
Introduction to Zymergen
Some data provided by Crunchbase
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Zymergen or any companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.
EQUITYZEN and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
To learn more about whether you're eligible, typical investment size, company valuation, and share price, request access here.